A mission born from expertise - and a personal resolve.
Blue Goat Cyber's story starts a decade before the company existed. In 2014, founder Christian Espinosa launched Alpine Security to help manufacturers navigate FDA expectations and protect the patients who depend on connected devices. After selling Alpine in 2020, a serious health scare gave Christian a firsthand appreciation for how much modern medicine depends on technology working safely, reliably, and securely.
In 2022, he founded Blue Goat Cyber with a sharper, more personal mission: protect lives by making sure medical devices are secure by design and ready for FDA scrutiny. Since then, the team has supported submissions for startups and global manufacturers alike - including Intuitive Surgical, bioMérieux, Nova Biomedical, Inogen, and Natera - across robotic surgery systems, diagnostic platforms, blood analyzers, wearables, and SaMD.
We're a service-disabled veteran-owned business with no cybersecurity-related rejections to date on FDA cybersecurity submissions. Every engagement is fixed-fee with retesting included, and if the FDA raises a cybersecurity question, we answer it at no extra cost until the cybersecurity portion is closed. That's how we structure the work; clearance is always the FDA's decision.
A health scare made the mission personal. Patients depend on connected devices working safely - every time. That's not a slogan. It's why we only do MedTech.
Why Blue Goat?
Christian is an avid mountain climber. On the trails, he's watched goats find footing on terrain that would stop almost anything else - relentless, resilient, focused on the next foothold. That's the discipline we wanted the company to embody.
The Blue is for the impossibly clear sky over a snow-covered ridgeline - clarity, trust, and limitless potential. Together it captures what we're trying to bring to MedTech security: steady footing on hard terrain, with no shortcuts to the summit.
Medical device security is patient safety.
Why we exist: so the devices people depend on can't be turned against them.
Connected medical devices that are secure by design and resilient for their entire service life.
The world we are working toward, with no end date.
By 2028, help medical device teams get 1,000 devices through FDA review with zero cybersecurity-driven rejections, and teach the industry to start cybersecurity early.
What we do daily, with a deadline: secure the devices in front of us, and through books, stages, podcasts, webinars, and mentoring, help every other team understand what cybersecurity means for their device before it costs them.
